Ageing, and treatment of hypertension.
There is now clear evidence of benefit from treating hypertension in patients over 60. However, the older patient is vulnerable to the effects of various antihypertensive drugs, which have therefore to be selected with care. Claims of differential efficacy and acceptability of different drugs with age are not well established; at present, the argument favouring a greater effect of ketanserin with age is one of the strongest.
Robertson
J I
JI
Janssen Research Foundation, Beerse, Belgium.
D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002320:Cardiovascular Physiological Phenomena; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D012107:Research Design / Q000592:standards
D000959:Antihypertensive Agents